Sign in →

Test Code VITAE Vitamin A and Vitamin E, Serum


Shipping Instructions


Ship specimen in amber vial to protect from light.



Specimen Required


Patient Preparation:

1. Fasting: 12 hours, required; infants should have specimen collected before next feeding.

2. Patient must not consume any alcohol for 24 hours before specimen collection.

Supplies: Amber Frosted Tube, 5 mL (T915)

Collection Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Submission Container/Tube: Amber vial

Specimen Volume: 1 mL serum

Collection Instructions: Within 2 hours of collection, centrifuge and aliquot serum into a light protected plastic vial.


Useful For

Assessment of vitamin A and vitamin E status

 

Monitoring vitamin A and vitamin E therapy

 

Evaluating individuals with intestinal malabsorption of lipids

Profile Information

Test ID Reporting Name Available Separately Always Performed
VITAP Vitamin A, S Yes, (Order VITA) Yes
VITE Vitamin E, S Yes Yes

Method Name

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

Vitamin A and Vitamin E, S

Specimen Type

Serum

Specimen Minimum Volume

Serum: 0.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 28 days LIGHT PROTECTED
  Frozen  28 days LIGHT PROTECTED
  Ambient  7 days LIGHT PROTECTED

Reject Due To

Gross hemolysis OK
Gross lipemia Reject
Gross icterus OK

Clinical Information

Vitamin A:

The level of vitamin A in the plasma or serum is a reflection of the quantities of vitamin A and carotene (provitamin A) ingested and absorbed by the intestine (carotene is converted to vitamin A by intestinal absorptive cells and hepatocytes).

 

Vitamin A plays an essential role in the function of the retina (adaptation to dim light), is necessary for growth and differentiation of epithelial tissue, and is required for growth of bone, reproduction, and embryonic development. Together with certain carotenoids, vitamin A also plays a critical role in immune function, with deficiency associated with increased susceptibility and severity of some infectious diseases.

 

Degenerative changes in eyes and skin are commonly observed in vitamin A deficiency. In developing countries, vitamin A deficiency is the principal preventable cause of blindness. Poor adaptation of vision to darkness (nyctalopia, night blindness) is an early symptom that may be followed by degenerative changes in the retina. Severe or prolonged deficiency leads to xerophthalmia, which can result in dry eye, corneal ulcers, Bitot spots, keratomalacia, and ultimately blindness. Skin changes such as dry skin, generalized xerosis, and phrynoderma are commonly observed in conjunction with vision disorders caused by vitamin A deficiency.

 

Vitamin A in excess can be toxic. In particular, chronic vitamin A intoxication is a concern in normal adults who ingest more than 15 mg per day and children who ingest more than 6 mg per day of vitamin A over a period of several months. Manifestations are various and include dry skin, cheilosis, glossitis, vomiting, alopecia, bone demineralization and pain, hypercalcemia, lymph node enlargement, hyperlipidemia, amenorrhea, and features of pseudotumor cerebri with increased intracranial pressure and papilledema. Liver fibrosis with portal hypertension may also result. Congenital malformations, like spontaneous abortions, craniofacial abnormalities, and valvular heart disease have been described in pregnant women taking vitamin A in excess. Consequently, in pregnancy, the daily dose of vitamin A should not exceed 3 mg.

 

Vitamin E (alpha-tocopherol):

Vitamin E is the generic term for two different groups of methylated phenol compounds with a chromane alcoholic core linked to poly-carbon chains (tocopherols and tocotrienols).

 

These vitamins are all free radical scavengers, with a-Tocopherol being the most potent one in humans, as most of the related compounds are not re-secreted by the liver, thus leading to much lower circulating concentrations.

 

Vitamin E deficiency is very rare and mostly seen in patients with extreme malabsorption of fat and in patients with abetalipoproteinemia, a rare inborn error of metabolism. Patients with these conditions may develop hemolytic anemia, peripheral neuropathy, myopathy, retinopathy, and immune deficiency.

 

There is a large body of scientific studies that indicates positive effects on outcomes of various diseases if regular Vitamin E supplementation is provided; however, several trials have shown evidence of increasing bleeding risks at high Vitamin E doses. Therefore, tables of tolerable doses in children and adults have been established, which should not be exceeded.

 

Deficiencies of vitamins A and E may arise from poor nutrition or from intestinal malabsorption. Individuals at risk, especially children, include those with bowel disease, pancreatic disease, chronic cholestasis, celiac disease, cystic fibrosis, and intestinal lymphangiectasia. Infantile cholangiopathies that may lead to malabsorption of vitamins A and E include intrahepatic dysplasia and rubella-related embryopathy.

Reference Values

VITAMIN A (RETINOL)

0-6 years: 11.3-64.7 mcg/dL

7-12 years: 12.8-81.2 mcg/dL

13-17 years: 14.4-97.7 mcg/dL

≥18 years: 32.5-78.0 mcg/dL

 

VITAMIN E (ALPHA-TOCOPHEROL)

0-17 years: 3.8-18.4 mg/L

≥18 years: 5.5-17.0 mg/L

Day(s) Performed

Monday through Friday, Sunday

Report Available

2 to 5 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

84446

84590